These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8917680)

  • 41. Natural antibody recognition of v-H-ras-induced 10T1/2 transformation.
    Tough DF; Chow DA
    Nat Immun Cell Growth Regul; 1991; 10(2):83-93. PubMed ID: 1652685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective lack of intercellular communication between transformed and nontransformed cells as a common property of chemical and oncogene transformation of BALB/c 3T3 cells.
    Yamasaki H; Hollstein M; Mesnil M; Martel N; Aguelon AM
    Cancer Res; 1987 Nov; 47(21):5658-64. PubMed ID: 3311356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutant H-ras overexpression inhibits drug and U.V. induced apoptosis.
    Fernandes RS; McGowan AJ; Cotter TG
    Anticancer Res; 1996; 16(4A):1691-705. PubMed ID: 8712688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of apoptosis in human tumour cells by okadaic acid.
    Song Q; Baxter GD; Kovacs EM; Findik D; Lavin MF
    J Cell Physiol; 1992 Dec; 153(3):550-6. PubMed ID: 1447316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Okadaic acid interferes with the maturation of human fetal kidney in serum-free culture.
    Brière N; Chailler P
    Biofactors; 1995 May; 5(1):19-23. PubMed ID: 7546214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A protein kinase C inhibitor induces phenotypic reversion of ras-transformed pancreatic cancer cells and cooperatively blocks tumor cell proliferation with an anti- ras peptide.
    Way D; Smith S; Sivendran S; Chie L; Kanovsky M; Brandt-Rauf PW; Chung DL; Michl J; Pincus MR
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):429-37. PubMed ID: 12107546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of protein phosphatases in malignant transformation.
    Nagao M; Sakai R; Kitagawa Y; Ikeda I; Sasaki K; Shima H; Sugimura T
    Princess Takamatsu Symp; 1989; 20():177-84. PubMed ID: 2562181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Normal and Ha-ras-1 oncogene transformed Buffalo rat liver (BRL) cells show differential resistance to cytoskeletal protein inhibitors.
    Theodoropoulos PA; Gravanis A; Saridakis I; Stournaras C
    Cell Biochem Funct; 1992 Dec; 10(4):281-8. PubMed ID: 1473269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suppression of dexamethasone-induced metallothionein expression and cis-diamminedichloroplatinum(II) resistance by v-mos.
    Basu A; Lazo JS
    Cancer Res; 1991 Feb; 51(3):893-6. PubMed ID: 1824827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. gamma-Glutamyltranspeptidase and the ras-induced transformation of a rat liver cell line.
    Sinha S; Marshall CJ; Neal GE
    Cancer Res; 1986 Mar; 46(3):1440-5. PubMed ID: 2867825
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Uridine kinase: altered subunit size or enzyme expression as a function of cell type, growth stimulation, or mutagenesis.
    Cheng N; Traut TW
    J Cell Biochem; 1987 Nov; 35(3):217-29. PubMed ID: 2826505
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective cytotoxicity of farnesylamine to pancreatic carcinoma cells and Ki-ras-transformed fibroblasts.
    Ura H; Obara T; Shudo R; Itoh A; Tanno S; Fujii T; Nishino N; Kohgo Y
    Mol Carcinog; 1998 Feb; 21(2):93-9. PubMed ID: 9496909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transformation with oncogenic Ras and the simian virus 40 T antigens induces caspase-dependent sensitivity to fatty acid biosynthetic inhibition.
    Xu S; Spencer CM; Munger J
    J Virol; 2015 Jun; 89(12):6406-17. PubMed ID: 25855740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction by the guanosine analogue oxanosine of reversion toward the normal phenotype of K-ras-transformed rat kidney cells.
    Itoh O; Kuroiwa S; Atsumi S; Umezawa K; Takeuchi T; Hori M
    Cancer Res; 1989 Feb; 49(4):996-1000. PubMed ID: 2643467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Caspase-3 is actively involved in okadaic acid-induced lens epithelial cell apoptosis.
    Li DW; Xiang H; Mao YW; Wang J; Fass U; Zhang XY; Xu C
    Exp Cell Res; 2001 Jun; 266(2):279-91. PubMed ID: 11399056
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ras mutation, irrespective of cell type and p53 status, determines a cell's destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase 1 and 2A.
    Rajesh D; Schell K; Verma AK
    Mol Pharmacol; 1999 Sep; 56(3):515-25. PubMed ID: 10462539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. H-ras-transformed NRK-52E renal epithelial cells have altered growth, morphology, and cytoskeletal structure that correlates with renal cell carcinoma in vivo.
    Best CJ; Tanzer LR; Phelps PC; Merriman RL; Boder GG; Trump BF; Elliget KA
    In Vitro Cell Dev Biol Anim; 1999 Apr; 35(4):205-14. PubMed ID: 10478800
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Massive accumulation of neutral lipids in cells conditionally transformed by an activated H-ras oncogene.
    Hirakawa T; Maruyama K; Kohl NE; Kodama T; Ruley HE
    Oncogene; 1991 Feb; 6(2):289-95. PubMed ID: 2000221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A strategy for screening anti-tumor drugs utilizing oncogenes encoded in retroviral vectors.
    Corbley MJ; Cherington V; Traxler PM; Lydon NB; Roberts TM
    Int J Cancer; 1996 Jun; 66(6):753-9. PubMed ID: 8647645
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of chromium effects on a rat liver epithelial cell line and their relevance to in vitro transformation.
    Briggs JA; Briggs RC
    Cancer Res; 1988 Nov; 48(22):6484-90. PubMed ID: 3180065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.